Anil Busimi started his professional career in 2003 at SCHOTT AG in Germany. He worked in different positions including business development manager for microarrays, project manager for new business, and consultant in corporate strategy and development. In 2005, he moved to the business segment Pharmaceutical Packaging and played a key role in building long-term business strategy, market intelligence, product management and innovation for pharmaceutical systems business. From August 2009 until June 2016, he held various positions in global product management for pre-fillable syringe business (glass and polymer). Currently, he is in the strategy & innovation team as senior global product manager for Cartridges and leads the iQ™ Platform market launch.
He holds M.Sc degree in Agriculture and Genetics and a MBA.
It’s a question we hear again and again. A question that has greater importance for pharmaceutical manufacturers as the popularity of prefilled syringes (PFSs) continues to rise and manufacturers must not only develop an effective drug, but a streamlined and safe drug delivery system. A question that shows how pharmaceutical packaging plays a significant role in drug success, even as choosing the “right” packaging material for a drug remains a hot area of debate.
The question is seemingly simple: Is glass or polymer the better material for PFSs? Each has its strengths and weaknesses after all. Ultimately, that is the wrong debate to be having. Before analyzing the benefits and drawbacks of each material, pharmaceutical manufacturers need to start by assessing the user need for each PFS application.
This presentation will discuss the following points: